Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jörg Kreuter
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Concepts & Ideas
Objects
Physiology
Devices
Living Beings
Procedures
Sign-in to see full Profile
Network (preview)
18
von Briesen, Hagen
17
Langer, Klaus
14
Zimmer, Andreas
12
Gelperina, Svetlana
6
Khalansky, Alexander
6
Kharkevich, DA
6
Alyautdin, Renad
6
Begley, David
6
Ramge, Peter
6
Rübsamen-Waigmann, Helga
5
Noe, CR
5
Werner, D
5
Lochmann, Dirk
5
Zobel, HP
5
Löbenberg, Raimar
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jörg Kreuter (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2010: Michaelis Martin; Kleinschmidt Malte C; Barth Susanne; Rothweiler Florian; Geiler Janina; Breitling Rainer; Mayer Bernd; Deubzer Hedwig; Witt Olaf; Kreuter Jörg; Doerr Hans Wilhelm; Cinatl Jaroslav; Cinatl Jindrich
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines.
Biochemical pharmacology 2010;79(2):130-6.
-
2009: Zensi Anja; Begley David; Pontikis Charles; Legros Celine; Mihoreanu Larisa; Wagner Sylvia; Büchel Claudia; von Briesen Hagen; Kreuter Jörg
Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.
Journal of controlled release : official journal of the Controlled Release Society 2009;137(1):78-86.
-
2009: Hekmatara T; Bernreuther C; Khalansky A S; Theisen A; Weissenberger J; Matschke J; Gelperina S; Kreuter J; Glatzel M
Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects.
Clinical neuropathology 2009;28(3):153-64.
-
2009: Ulbrich Karsten; Hekmatara Telli; Herbert Elisabeth; Kreuter Jörg
Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2009;71(2):251-6.
-
2008: Anhorn Marion G; Wagner Sylvia; Kreuter Jörg; Langer Klaus; von Briesen Hagen
Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles.
Bioconjugate chemistry 2008;19(12):2321-31.
-
2008: Kreuter Jörg; Gelperina Svetlana
Use of nanoparticles for cerebral cancer.
Tumori 2008;94(2):271-7.
-
2007: Dreis S; Rothweiler F; Michaelis M; Cinatl J; Kreuter J; Langer K
Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.
International journal of pharmaceutics 2007;341(1-2):207-14.
-
2007: Pereverzeva E; Treschalin I; Bodyagin D; Maksimenko O; Langer K; Dreis S; Asmussen B; Kreuter J; Gelperina S
Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: focus on cardio- and testicular toxicity.
International journal of pharmaceutics 2007;337(1-2):346-56.
-
2007: Kreuter Jörg; Hekmatara Telli; Dreis Sebastian; Vogel Tikva; Gelperina Svetlana; Langer Klaus
Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain.
Journal of controlled release : official journal of the Controlled Release Society 2007;118(1):54-8.
-
2007: Kreuter Jörg
Nanoparticles--a historical perspective.
International journal of pharmaceutics 2007;331(1):1-10.
-
2007: Petri B; Bootz A; Khalansky A; Hekmatara T; Müller R; Uhl R; Kreuter J; Gelperina S
Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants.
Journal of controlled release : official journal of the Controlled Release Society 2007;117(1):51-8.
-
2006: De Juan Berta Sanchez; Von Briesen Hagen; Gelperina Svetlana E; Kreuter Jörg
Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays.
Journal of drug targeting 2006;14(9):614-22.
-
2006: Ambruosi Alessandra; Gelperina Svetlana; Khalansky Alexander; Tanski Sandra; Theisen Alf; Kreuter Jörg
Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model.
Journal of microencapsulation 2006;23(5):582-92.
-
2006: Michaelis K; Hoffmann M M; Dreis S; Herbert E; Alyautdin R N; Michaelis M; Kreuter J; Langer K
Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain.
The Journal of pharmacology and experimental therapeutics 2006;317(3):1246-53.
-
2006: Ambruosi Alessandra; Khalansky Alexander S; Yamamoto Hiromitsu; Gelperina Svetlana E; Begley David J; Kreuter Jörg
Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats.
Journal of drug targeting 2006;14(2):97-105.
-
2005: Ambruosi Alessandra; Yamamoto Hiromitsu; Kreuter Jörg
Body distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats.
Journal of drug targeting 2005;13(10):535-42.
-
2005: Dinauer Norbert; Balthasar Sabine; Weber Carolin; Kreuter Jörg; Langer Klaus; von Briesen Hagen
Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes.
Biomaterials 2005;26(29):5898-906.
-
2005: Mayer Gottfried; Vogel Vitali; Weyermann Jörg; Lochmann Dirk; van den Broek Jacomina A; Tziatzios Christos; Haase Winfried; Wouters Daan; Schubert Ulrich S; Zimmer Andreas; Kreuter Jörg; Schubert Dieter
Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction.
Journal of controlled release : official journal of the Controlled Release Society 2005;106(1-2):181-7.
-
2005: Bootz Alexander; Russ Thomas; Gores Friedhelm; Karas Michael; Kreuter Jörg
Molecular weights of poly(butyl cyanoacrylate) nanoparticles determined by mass spectrometry and size exclusion chromatography.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2005;60(3):391-9.
-
2005: Junghans Monika; Loitsch Stefan M; Steiniger Sebastian C J; Kreuter Jörg; Zimmer Andreas
Cationic lipid-protamine-DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2005;60(2):287-94.
-
2005: Balthasar Sabine; Michaelis Kerstin; Dinauer Norbert; von Briesen Hagen; Kreuter Jörg; Langer Klaus
Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.
Biomaterials 2005;26(15):2723-32.
-
2005: Schuller Alina Maria; Windolf Joachim; Blaheta Roman; Cinatl Jindrich; Kreuter Jörg; Wimmer-Greinecker Gerhard; Moritz Anton; Scholz Martin
Degradation of microvascular brain endothelial cell beta-catenin after co-culture with activated neutrophils from patients undergoing cardiac surgery with prolonged cardiopulmonary bypass.
Biochemical and biophysical research communications 2005;329(2):616-23.
-
2005: Vogel Vitali; Lochmann Dirk; Weyermann Jörg; Mayer Gottfried; Tziatzios Christos; van den Broek Jacomina A; Haase Winfried; Wouters Daan; Schubert Ulrich S; Kreuter Jörg; Zimmer Andreas; Schubert Dieter
Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution.
Journal of controlled release : official journal of the Controlled Release Society 2005;103(1):99-111.
-
2004: Lochmann D; Vogel V; Weyermann J; Dinauer N; von Briesen H; Kreuter J; Schubert D; Zimmer A
Physicochemical characterization of protamine-phosphorothioate nanoparticles.
Journal of microencapsulation 2004;21(6):625-41.
-
2004: Weyermann Jörg; Lochmann Dirk; Georgens Christiane; Rais Isam; Kreuter Jörg; Karas Michael; Wolkenhauer Markus; Zimmer Andreas
Physicochemical characterisation of cationic polybutylcyanoacrylate-nanoparticles by fluorescence correlation spectroscopy.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;58(1):25-35.
-
2004: Kreuter Jörg
Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.
Journal of nanoscience and nanotechnology 2004;4(5):484-8.
-
2004: Dinauer Norbert; Lochmann Dirk; Demirhan Ilhan; Bouazzaoui Abdellatif; Zimmer Andreas; Chandra Angelika; Kreuter Jörg; von Briesen Hagen
Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation.
Journal of controlled release : official journal of the Controlled Release Society 2004;96(3):497-507.
-
2004: Wartlick Heidrun; Spänkuch-Schmitt Birgit; Strebhardt Klaus; Kreuter Jörg; Langer Klaus
Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles.
Journal of controlled release : official journal of the Controlled Release Society 2004;96(3):483-95.
-
2004: Steiniger Sebastian C J; Kreuter Jörg; Khalansky Alexander S; Skidan Igor N; Bobruskin Alexey I; Smirnova Zoya S; Severin Sergey E; Uhl Reiner; Kock Martin; Geiger Kathrin D; Gelperina Svetlana E
Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles.
International journal of cancer. Journal international du cancer 2004;109(5):759-67.
-
2004: Latsch Silvia; Selzer Torsten; Fink Lothar; Horstmann Michael; Kreuter Jörg
Use of isothermal heat conduction microcalorimetry, X-ray diffraction, and optical microscopy for characterisation of crystals grown in steroid combination-containing transdermal drug delivery systems.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;57(2):397-410.
-
2004: Latsch Silvia; Selzer Torsten; Fink Lothar; Kreuter Jörg
Determination of the physical state of norethindrone acetate containing transdermal drug delivery systems by isothermal microcalorimetry, X-ray diffraction, and optical microscopy.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;57(2):383-95.
-
2004: Bootz Alexander; Vogel Vitali; Schubert Dieter; Kreuter Jörg
Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;57(2):369-75.
-
2004: Wartlick Heidrun; Michaelis Kerstin; Balthasar Sabine; Strebhardt Klaus; Kreuter Jörg; Langer Klaus
Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells.
Journal of drug targeting 2004;12(7):461-71.
-
2003: Rhaese Stephanie; von Briesen Hagen; Rübsamen-Waigmann Helga; Kreuter Jörg; Langer Klaus
Human serum albumin-polyethylenimine nanoparticles for gene delivery.
Journal of controlled release : official journal of the Controlled Release Society 2003;92(1-2):199-208.
-
2003: Latsch Silvia; Selzer Torsten; Fink Lothar; Kreuter Jörg
Crystallisation of estradiol containing TDDS determined by isothermal microcalorimetry, X-ray diffraction, and optical microscopy.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2003;56(1):43-52.
-
2003: Aliautdin R N; Kreuter J; Kharkevich D A
[Drug delivery to the brain with nanoparticles]
Eksperimental'naia i klinicheskaia farmakologiia 2003;66(2):65-8.
-
2003: Kreuter Jörg; Ramge Peter; Petrov Valery; Hamm Stefan; Gelperina Svetlana E; Engelhardt Britta; Alyautdin Renad; von Briesen Hagen; Begley David J
Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles.
Pharmaceutical research 2003;20(3):409-16.
-
2002: Kreuter Jörg; Shamenkov Dmitry; Petrov Valery; Ramge Peter; Cychutek Klaus; Koch-Brandt Claudia; Alyautdin Renad
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Journal of drug targeting 2002;10(4):317-25.
-
2002: Swatschek Dieter; Schatton Wolfgang; Kellermann Josef; Müller Werner E G; Kreuter Jörg
Marine sponge collagen: isolation, characterization and effects on the skin parameters surface-pH, moisture and sebum.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2002;53(1):107-13.
-
2002: Gelperina S E; Khalansky A S; Skidan I N; Smirnova Z S; Bobruskin A I; Severin S E; Turowski B; Zanella F E; Kreuter J
Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma.
Toxicology letters 2002;126(2):131-41.
-
2001: Alyaudtin R N; Reichel A; Löbenberg R; Ramge P; Kreuter J; Begley D J
Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro.
Journal of drug targeting 2001;9(3):209-21.
-
2001: Kreuter J
Nanoparticulate systems for brain delivery of drugs.
Advanced drug delivery reviews 2001;47(1):65-81.
-
2001: Junghans M; Kreuter J; Zimmer A
Phosphodiester and phosphorothioate oligonucleotide condensation and preparation of antisense nanoparticles.
Biochimica et biophysica acta 2001;1544(1-2):177-88.
-
2001: Skidan I N; Bobruskin A I; Guliaev A E; Shalkharbaeva S D; Severin S E; Steinniger S; Kreuter J; Gel'perina S E
[Optimization of "Photosens" pharmakokinetics by biodegradable nanospheres]
Antibiotiki i khimioterapii?a = Antibiotics and chemoterapy [sic] / Ministerstvo meditsinskoi i mikrobiologicheskoi promyshlennosti SSSR 2001;46(4):6-10.
-
2000: Ramge P; Unger R E; Oltrogge J B; Zenker D; Begley D; Kreuter J; Von Briesen H
Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells.
The European journal of neuroscience 2000;12(6):1931-40.
-
2000: Langer K; Coester C; Weber C; von Briesen H; Kreuter J
Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;49(3):303-7.
-
2000: Zobel H P; Junghans M; Maienschein V; Werner D; Gilbert M; Zimmermann H; Noe C; Kreuter J; Zimmer A
Enhanced antisense efficacy of oligonucleotides adsorbed to monomethylaminoethylmethacrylate methylmethacrylate copolymer nanoparticles.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;49(3):203-10.
-
2000: Junghans M; Kreuter J; Zimmer A
Antisense delivery using protamine-oligonucleotide particles.
Nucleic acids research 2000;28(10):E45.
-
2000: Coester C J; Langer K; van Briesen H; Kreuter J
Gelatin nanoparticles by two step desolvation--a new preparation method, surface modifications and cell uptake.
Journal of microencapsulation 2000;17(2):187-93.
-
2000: Weber C; Kreuter J; Langer K
Desolvation process and surface characteristics of HSA-nanoparticles.
International journal of pharmaceutics 2000;196(2):197-200.
-
2000: Coester C; Kreuter J; von Briesen H; Langer K
Preparation of avidin-labelled gelatin nanoparticles as carriers for biotinylated peptide nucleic acid (PNA).
International journal of pharmaceutics 2000;196(2):147-9.
-
2000: Weber C; Coester C; Kreuter J; Langer K
Desolvation process and surface characterisation of protein nanoparticles.
International journal of pharmaceutics 2000;194(1):91-102.
-
1999: Ramge P; Kreuter J; Lemmer B
Circadian phase-dependent antinociceptive reaction in mice determined by the hot-plate test and the tail-flick test after intravenous injection of dalargin-loaded nanoparticles.
Chronobiology international 1999;16(6):767-77.
-
1999: Gulyaev A E; Gelperina S E; Skidan I N; Antropov A S; Kivman G Y; Kreuter J
Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.
Pharmaceutical research 1999;16(10):1564-9.
-
1999: Zobel H P; Stieneker F; Atmaca-Abdel Aziz S; Gilbert M; Werner D; Noe C R; Kreuter J; Zimmer A
Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part II: characterization of antisense oligonucleotides loaded copolymer nanoparticles.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1999;48(1):1-12.
-
1999: Zobel H P; Werner D; Gilbert M; Noe C R; Stieneker F; Kreuter J; Zimmer A
Effect of ultrasonication on the stability of oligonucleotides adsorbed on nanoparticles and liposomes.
Journal of microencapsulation 1999;16(4):501-9.
-
1999: Selzer T; Radau M; Kreuter J
The use of isothermal heat conduction microcalorimetry to evaluate drug stability in tablets.
International journal of pharmaceutics 1999;184(2):199-206.
-
1999: Zobel H P; Zimmer A; Atmaca-Abdel Aziz S; Gilbert M; Werner D; Noe C R; Kreuter J; Stieneker F
Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part I: Synthesis of monomers, dependence of the physical properties on the polymerization methods.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1999;47(3):203-13.
-
1999: Müller B; Kreuter J
Enhanced transport of nanoparticle associated drugs through natural and artificial membranes--a general phenomenon?
International journal of pharmaceutics 1999;178(1):23-32.
-
1999: Araujo L; Löbenberg R; Kreuter J
Influence of the surfactant concentration on the body distribution of nanoparticles.
Journal of drug targeting 1999;6(5):373-85.
-
1998: Ueda M; Iwara A; Kreuter J
Influence of the preparation methods on the drug release behaviour of loperamide-loaded nanoparticles.
Journal of microencapsulation 1998;15(3):361-72.
-
1998: Berthold A; Cremer K; Kreuter J
Collagen microparticles: carriers for glucocorticosteroids.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1998;45(1):23-9.
-
1998: Löbenberg R; Araujo L; von Briesen H; Rodgers E; Kreuter J
Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats.
Journal of controlled release : official journal of the Controlled Release Society 1998;50(1-3):21-30.
-
1998: Aliautdin R N; Petrov V E; Langer K; Berthold A; Kreuter J; Kharkevich D A
[The delivery of loperamide to the brain by using polybutyl cyanoacrylate nanoparticles]
Eksperimental'naia i klinicheskaia farmakologiia 1998;61(1):17-20.
-
1998: Mooren F C; Berthold A; Domschke W; Kreuter J
Influence of chitosan microspheres on the transport of prednisolone sodium phosphate across HT-29 cell monolayers.
Pharmaceutical research 1998;15(1):58-65.
-
1998: Alyautdin R N; Tezikov E B; Ramge P; Kharkevich D A; Begley D J; Kreuter J
Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.
Journal of microencapsulation 1998;15(1):67-74.
-
1998: Landry F B; Bazile D V; Spenlehauer G; Veillard M; Kreuter J
Peroral administration of 14C-poly(D,L-lactic acid) nanoparticles coated with human serum albumin or polyvinyl alcohol to guinea pigs.
Journal of drug targeting 1998;6(4):293-307.
-
1998: Löbenberg R; Maas J; Kreuter J
Improved body distribution of 14C-labelled AZT bound to nanoparticles in rats determined by radioluminography.
Journal of drug targeting 1998;5(3):171-9.
-
1997: Zobel H P; Kreuter J; Werner D; Noe C R; Kümel G; Zimmer A
Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotides.
Antisense & nucleic acid drug development 1997;7(5):483-93.
-
1997: Ueda M; Kreuter J
Optimization of the preparation of loperamide-loaded poly (L-lactide) nanoparticles by high pressure emulsification-solvent evaporation.
Journal of microencapsulation 1997;14(5):593-605.
-
1997: Alyautdin R N; Petrov V E; Langer K; Berthold A; Kharkevich D A; Kreuter J
Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
Pharmaceutical research 1997;14(3):325-8.
-
1996: Kreuter J
Nanoparticles and microparticles for drug and vaccine delivery.
Journal of anatomy 1996;189 ( Pt 3)():503-5.
-
1996: Löbenberg R; Kreuter J
Macrophage targeting of azidothymidine: a promising strategy for AIDS therapy.
AIDS research and human retroviruses 1996;12(18):1709-15.
-
1996: Borchard G; Kreuter J
The role of serum complement on the organ distribution of intravenously administered poly (methyl methacrylate) nanoparticles: effects of pre-coating with plasma and with serum complement.
Pharmaceutical research 1996;13(7):1055-8.
-
1996: Bender A R; von Briesen H; Kreuter J; Duncan I B; Rübsamen-Waigmann H
Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro.
Antimicrobial agents and chemotherapy 1996;40(6):1467-71.
-
1996: Aliautdin R N; Petrov V E; Ivanov A A; Kreuter J; Kharkevich D A
[Transport of the hexapeptide dalargin across the hemato-encephalic barrier into the brain using polymer nanoparticles]
Eksperimental'naia i klinicheskaia farmakologiia 1996;59(3):57-60.
-
1996: Landry F B; Bazile D V; Spenlehauer G; Veillard M; Kreuter J
Degradation of poly(D,L-lactic acid) nanoparticles coated with albumin in model digestive fluids (USP XXII).
Biomaterials 1996;17(7):715-23.
-
1995: Kreuter J; Alyautdin R N; Kharkevich D A; Ivanov A A
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles).
Brain research 1995;674(1):171-4.
-
1995: Stieneker F; Kersten G; van Bloois L; Crommelin D J; Hem S L; Löwer J; Kreuter J
Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations.
Vaccine 1995;13(1):45-53.
-
1995: Rössler B; Kreuter J; Scherer D
Collagen microparticles: preparation and properties.
Journal of microencapsulation 1995;12(1):49-57.
-
1995: Kreuter J
Nanoparticles as adjuvants for vaccines.
Pharmaceutical biotechnology 1995;6():463-72.
-
1994: Zimmer A; Mutschler E; Lambrecht G; Mayer D; Kreuter J
Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle-delivery-system.
Pharmaceutical research 1994;11(10):1435-42.
-
1994: Kreuter J
Drug targeting with nanoparticles.
European journal of drug metabolism and pharmacokinetics 1994;19(3):253-6.
-
1994: Schäfer V; von Briesen H; Rübsamen-Waigmann H; Steffan A M; Royer C; Kreuter J
Phagocytosis and degradation of human serum albumin microspheres and nanoparticles in human macrophages.
Journal of microencapsulation 1994;11(3):261-9.
-
1994: Bender A; Schfer V; Steffan A M; Royer C; Kreuter J; Rübsamen-Waigmann H; von Briesen H
Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles.
Research in virology 1994;145(3-4):215-20.
-
1994: Rössler B; Kreuter J; Ross G
Effect of collagen microparticles on the stability of retinol and its absorption into hairless mouse skin in vitro.
Die Pharmazie 1994;49(2-3):175-9.
-
1994: Schäfer V; Kreuter J; Rübsamen-Waigmann H; Gerte S; von Briesen H
Influence of HIV-infection on the phagocytic activity of monocytes/macrophages and granulocytes.
Clinical and diagnostic virology 1994;1(5-6):279-87.
-
1994: Borchardt G; Brandriss S; Kreuter J; Margel S
Body distribution of 75Se-radiolabeled silica nanoparticles covalently coated with omega-functionalized surfactants after intravenous injection in rats.
Journal of drug targeting 1994;2(1):61-77.
-
1993: Gido C; Langguth P; Kreuter J; Winter G; Woog H; Mutschler E
Conventional versus novel conditions for the in vitro dissolution testing of parenteral slow release formulations: application to doxepin parenteral dosage forms.
Die Pharmazie 1993;48(10):764-9.
-
1993: Beck P; Kreuter J; Reszka R; Fichtner I
Influence of polybutylcyanoacrylate nanoparticles and liposomes on the efficacy and toxicity of the anticancer drug mitoxantrone in murine tumour models.
Journal of microencapsulation 1993;10(1):101-14.
-
1993: Scherer D; Mooren F C; Kinne R K; Kreuter J
In vitro permeability of PBCA nanoparticles through porcine small intestine.
Journal of drug targeting 1993;1(1):21-7.
-
1993: Borchard G; Kreuter J
Interaction of serum components with poly(methylmethacrylate) nanoparticles and the resulting body distribution after intravenous injection in rats.
Journal of drug targeting 1993;1(1):15-9.
-
1992: Schäfer V; von Briesen H; Andreesen R; Steffan A M; Royer C; Tröster S; Kreuter J; Rübsamen-Waigmann H
Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages: a possibility for antiviral drug targeting.
Pharmaceutical research 1992;9(4):541-6.
-
1992: Tröster S D; Kreuter J
Influence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly(methyl methacrylate) nanoparticles.
Journal of microencapsulation 1992;9(1):19-28.
-
1991: Zimmer A; Kreuter J; Robinson J R
Studies on the transport pathway of PBCA nanoparticles in ocular tissues.
Journal of microencapsulation 1991;8(4):497-504.
-
1991: Cappel M J; Kreuter J
Effect of nanoparticles on transdermal drug delivery.
Journal of microencapsulation 1991;8(3):369-74.
-
1991: Stieneker F; Kreuter J; Löwer J
High antibody titres in mice with polymethylmethacrylate nanoparticles as adjuvant for HIV vaccines.
AIDS (London, England) 1991;5(4):431-5.
-
1990: Beck P; Scherer D; Kreuter J
Separation of drug-loaded nanoparticles from free drug by gel filtration.
Journal of microencapsulation 1990;7(4):491-6.
-
1990: Jaehnke R W; Kreuter J; Ross G
Interaction of rubber closures with powders for parenteral administration.
Journal of parenteral science and technology : a publication of the Parenteral Drug Association 1990;44(5):282-8.
-
1989: Diepold R; Kreuter J; Himber J; Gurny R; Lee V H; Robinson J R; Saettone M F; Schnaudigel O E
Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles).
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 1989;227(2):188-93.
-
1988: Kreuter J
Possibilities of using nanoparticles as carriers for drugs and vaccines.
Journal of microencapsulation 1988;5(2):115-27.
Sign-in to see more
